CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight

Go back to CD19 Inhibitors Market to Witness Significant Expansion During the Forecast Period (2025-2034) as Autoimmune and Oncology Pipelines Accelerate | DelveInsight
(NASDAQ: ADAG) Delayed: 4.47 -0.31 (6.49%)
Previous Close $4.78    52 Week High
Open $4.65    52 Week Low
Day High $4.78    P/E N/A 
Day Low $4.41    EPS
Volume 81,655       

(NASDAQ: AUTL) Delayed: 1.58 --0 (-0%)
Previous Close $1.58    52 Week High
Open $1.60    52 Week Low
Day High $1.72    P/E N/A 
Day Low $1.57    EPS
Volume 1,442,603